Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2012
10/26/2012WO2012143588A1 Fluorescent markers
10/26/2012WO2012143577A1 Encoded particles
10/26/2012WO2012143535A2 Method for detecting at least one carbapenem resistance mechanism by means of mass spectrometry
10/26/2012WO2012143514A1 Method for the diagnosis of liver injury based on a metabolomic profile
10/26/2012WO2012143498A1 Bcma-based stratification and therapy for multiple myeloma patients
10/26/2012WO2012143463A1 Analytical method to investigate binding of analyte ligands to cells
10/26/2012WO2012143212A1 Method and device for analyzing tobacco smoke
10/26/2012WO2012143202A1 Detection and analysis of oil-based contaminants in organic material
10/26/2012WO2012143201A1 Fluorescence control
10/26/2012WO2012143196A1 Method of measuring capillary rheology by speed ramp
10/26/2012WO2012142806A1 Method and device for gold immune quantitative detection on basis of inbuilt ccd image acquisition
10/26/2012WO2012142763A1 Blood typing devices and methods for testing blood type
10/26/2012WO2012142664A1 Method and device for trapping and analysing cells and the like
10/26/2012WO2012118974A3 Detection of human endogenous retrovirus expression in cancer and normal cells
10/26/2012WO2012106556A3 Methods and compositons relating to inhibition of igf-1r
10/26/2012WO2012106469A3 Methods for treating infections by targeting microbial h2s-producing enzymes
10/26/2012WO2012102773A3 Cancer diagnosis by measuring polyisoprenylated methylated protein methyl esterase activity
10/26/2012WO2012099881A3 Mutant proteins as cancer-specific biomarkers
10/26/2012WO2012088268A3 Modulators for sirt6 and assays for screening same
10/26/2012WO2012088195A3 Device and methods for the detection of cervical disease
10/26/2012WO2012087797A3 Method to characterize underground formation
10/26/2012WO2012083260A9 Methods and apparatus for enhanced recovery of cells and of cell-enriched matrix from tissue samples
10/26/2012WO2012080662A3 Method for predicting the response to a treatment against hepatitis c
10/26/2012WO2012071516A3 Devices and methods for the diagnosis and treatment of wounds using biomarkers
10/26/2012WO2012018948A3 Combination therapy for the treatment of prostate carcinoma
10/26/2012CA2833895A1 Water treatment systems and methods
10/26/2012CA2833857A1 Microfluidic system for controlling the concentration of molecules for stimulating a target
10/26/2012CA2833654A1 Immunoassay
10/26/2012CA2833641A1 Apparatus and method for cure monitoring and process control in glass fiber forming operation
10/26/2012CA2833638A1 Method for online determination of cure status of glass fiber products
10/26/2012CA2833636A1 Antibodies and other molecules that bind b7-h1 and pd-1
10/26/2012CA2833534A1 Molecular subtyping, prognosis and treatment of prostate cancer
10/26/2012CA2833497A1 Analyzing the expression of biomarkers in cells with moments
10/26/2012CA2833456A1 Method of detecting at least one mechanism of resistance to carbapenems by mass spectrometry
10/26/2012CA2833454A1 Method of detecting at least one mechanism of resistance to cephalosporins by mass spectrometry
10/26/2012CA2833375A1 Methods of using mirna from bodily fluids for early detection and monitoring of mild cognitive impairment (mci) and alzheimer's disease (ad)
10/26/2012CA2833348A1 Biomarkers for the treatment of multiple myeloma
10/26/2012CA2833295A1 Analyzing the expression of biomarkers in cells with clusters
10/26/2012CA2833084A1 Apparatus and method for measuring the flow-rate of different fluids present in multiphase streams
10/26/2012CA2833076A1 Methods for determining ligand binding to a target protein using a thermal shift assay
10/26/2012CA2832510A1 Bcma-based stratification and therapy for multiple myeloma patients
10/26/2012CA2831974A1 Methods for isolating and quantifying antigen from vaccines
10/26/2012CA2831003A1 Methods for detecting contaminants in solutions containing glucose polymers
10/25/2012US20120272347 Chitosan-alginate scaffold cell culture system and related methods
10/25/2012US20120272342 Mouse artificial chromosome vector
10/25/2012US20120272341 Novel gene disruptions, compositions and methods relating thereto
10/25/2012US20120271794 Method for managing treatment of a patient health condition with a pda based system
10/25/2012US20120271124 Thrombospondin Fragments and Uses Thereof In Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents
10/25/2012US20120271036 Solution Assay and High Through-Put Screen to Probe Interaction Between Human Cullin-Ring Ligase Complex and HIV-VIF Protein
10/25/2012US20120271035 T1r taste receptors and genes encoding same
10/25/2012US20120270938 Small molecules that covalently modify transthyretin
10/25/2012US20120270923 Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer
10/25/2012US20120270900 Novel method of treatment
10/25/2012US20120270844 Methods for treating alzheimer's disease
10/25/2012US20120270836 Therapeutic approaches for treating alzheimer's disease
10/25/2012US20120270815 Modified-galactosyl ceramides for staining and stimulating natural killer t cells
10/25/2012US20120270812 Compositions, methods, and kits for determining an alkyl transferase
10/25/2012US20120270809 Human transmembrane proteins
10/25/2012US20120270802 Binding molecules for the treatment of myeloid cell malignancies
10/25/2012US20120270794 Polymorphisms associated with parkinson's disease
10/25/2012US20120270757 Site-specific labeling of affinity tags in fusion proteins
10/25/2012US20120270752 Analyzing the expression of biomarkers in cells with moments
10/25/2012US20120270749 Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
10/25/2012US20120270747 Method of predicting risk of pre-term birth
10/25/2012US20120270744 Methods to determine if a subject will respond to a bcr-abl inhibitor
10/25/2012US20120270742 Obesity Dependent Adipokine Biomarkers for Prostate Cancer
10/25/2012US20120270741 Biomarker discovery in complex biological fluid using bead or particle based libraries and diagnostic kits and therapeutics
10/25/2012US20120270337 Method for making and using a diagnostic element
10/25/2012US20120270325 System and method for evaluating the performance of a pump
10/25/2012US20120270324 Method for testing the tightness of water conducting components in a housing
10/25/2012US20120270316 Methods and reagents for preserving rna in cell and tissue s amples
10/25/2012US20120270265 Methods of obtaining a specific binding member that binds eotaxin
10/25/2012US20120270246 Procollagen c-proteinase enhancer (pcpe) biomarker for bone formation
10/25/2012US20120270245 Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin ii
10/25/2012US20120270244 Means and Methods for Diagnosing and/or Treating a Subject at Risk of Developing Heart Failure
10/25/2012US20120270243 Diagnosing and Managing Venous Thromboembolism and Intracardiac Thrombi Using a Provoked D-dimer Test
10/25/2012US20120270242 Immunochemical detection of single target entities
10/25/2012US20120270239 Melanoma prognostic model using tissue microarrays and genetic algorithms
10/25/2012US20120270238 Peptides That Bind the Alpha-Fetoprotein (AFP) Receptor and Uses Thereof
10/25/2012US20120270237 Methods for the identification of kinase interacting molecules and for the purification of kinase proteins
10/25/2012US20120270235 Membrane biosensor having multi-hole film attached thereto and method for measuring immunological reaction or enzymatic reaction using the same
10/25/2012US20120270231 Lattice-mismatched core-shell quantum dots
10/25/2012US20120270230 Mutant g-protein coupled receptors and methods for selecting them
10/25/2012US20120270229 Device for detection of analytes and uses thereof
10/25/2012US20120270222 Method for the Efficiency-Corrected Real-Time Quantification of Nucleic Acids
10/25/2012US20120270219 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
10/25/2012US20120270209 Systems, devices, and methods for specific capture and release of biological sample components
10/25/2012US20120270208 Synthetic antigens for the detection of antibodies to hepatitis c virus
10/25/2012US20120270207 Analyte detection
10/25/2012US20120270206 Systems and Methods for Analyzing Nucleic Acid Sequences
10/25/2012US20120269936 Controller and method of controlling an integrated system for dispensing and blending/mixing beverage ingredients
10/25/2012US20120269935 Systems and methods for processing comestibles
10/25/2012US20120269910 Method for Testing a Substance Which is Potentially Active in the Field of Lipolysis and its Mainly Cosmetic Use
10/25/2012US20120269843 S. epidermidis antigens
10/25/2012US20120269825 Methods of modulating the ox40 receptor to treat cancer
10/25/2012US20120269823 Virulent isolate of neospora caninum and its uses
10/25/2012US20120269815 Neurotrophins and uses thereof
10/25/2012US20120269814 Anti-c mpl antibodies
10/25/2012US20120269810 Methods and compositions for panic disorders
10/25/2012US20120269799 Diagnostic and treatment methods using a ligand library
1 ... 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 ... 3937